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ARTICLE
Loss-of-Function Mutations in Growth Differentiation Factor-1
(GDF1) Are Associated with Congenital Heart Defects in Humans
J. D. Karkera, J. S. Lee, E. Roessler, S. Banerjee-Basu, M. V. Ouspenskaia, J. Mez, E. Goldmuntz,
P. Bowers, J. Towbin, J. W. Belmont, A. D. Baxevanis, A. F. Schier, and M. Muenke
Congenital heart defects (CHDs) are among the most common birth defects in humans (incidence 8–10 per 1,000 live
births). Although their etiology is often poorly understood, most are considered to arise from multifactorial influences,
including environmental and genetic components, as well as from less common syndromic forms. We hypothesized that
disturbances in left-right patterning could contribute to the pathogenesis of selected cardiac defects by interfering with
the extrinsic cues leading to the proper looping and vessel remodeling of the normally asymmetrically developed heart
and vessels. Here, we show that heterozygous loss-of-function mutations in the human GDF1 gene contribute to cardiac
defects ranging from tetralogy of Fallot to transposition of the great arteries and that decreased TGF-b signaling provides
a framework for understanding their pathogenesis. These findings implicate perturbations of the TGF-b signaling pathway
in the causation of a major subclass of human CHDs.
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Congenital heart defects (CHDs) are a major cause of
morbidity and mortality in human newborns. Recent ad-
vances in our understanding of the molecular basis of
embryonic patterning of the developing heart hold great
promise for elucidating the underlying mechanisms of
some of these cardiac malformations.1,2 Conceptually,
these CHDs can be caused by intrinsically defective pat-
terning within the developing heart tissues or, alterna-
tively, by mispatterning due to the failure of instructive
extrinsic cues during embryonic patterning.3 The linear
heart tube typically loops to the right in vertebrate em-
bryos, and this represents the first overt sign of the pre-
viously established molecular cascade governing asym-
metric expression of genes—such as Nodal (MIM 601265)
and NODAL, Leftyb (LEFTY1 [MIM 603037] and LEFTY2
[MIM 601877]), and Pitx2 (PITX2 [MIM 601542])—in
the left lateral plate mesoderm (reviewed in the work of
Hamada et al.4). These asymmetric factors provide left-
right (L-R) positional information to developing organs,
such as the lungs, heart, gut, and brain. In addition, CHDs
are commonly seen in the multiorgan pathological spec-
trum of human laterality defects,5 some of which can be
explained by attenuated TGF-b signaling.6 Furthermore,
TGF-b signals, such as Nodal and Gdf1, have been shown
to be essential for the establishment and maintenance of
the asymmetric cues affecting organ morphogenesis.4,7–9
TGF-b ligands function in diverse roles during devel-
opment, including the induction of mesendoderm and
determination of the body axes. GDF1 (MIM *602880)10,
11 is structurally related to and functionally homologous
to Xenopus Vg112,13 and is within the activin-like subclass
of TGF-b signaling molecules (activin/Nodal/Vg1). Signal
transduction by this subfamily culminates in receptor-
mediated phosphorylation of receptor-regulated R-Smad2
(SMAD2 [MIM 601366]) or R-Smad3 (SMAD3 [MIM
603109]) and in the assembly of R-Smad4 (SMAD4 [MIM
600993]) complexes together with cotranscription fac-
tors, such as FoxH1 (FOXH1 [MIM 603621]), onto target
genes.14,15
Murine Gdf1 is upstream of a cascade of left-sided de-
terminants that participate in the establishment and main-
tenance of L-R signals governing asymmetric organo-
genesis, including the heart and great vessels.8,9 Pitx2 is
one such asymmetrically expressed downstream target of
this L-R cascade, and, in mice, loss of function of this
bicoid-class transcription factor by gene targeting causes
transposition of the great arteries (TGA, the most common
form of which is “dextro-looped TGA” [MIM #608808]),
double-outlet right ventricle (DORV), persistent truncus
arteriosus, and atrial isomerism.16 These observations
strengthen the hypothesis that L-R patterning signals
can directly or indirectly affect cardiac development and
might help to explain CHD manifestations in humans.
Gdf1 is synthesized as a preproprotein that is post-
translationally processed in a regulated fashion into its
mature form, containing the classic TGF-b structure (fig.
1), by tissue-specific convertases.17 Absence of Gdf1 in the
mouse is associated with disturbances in L-R patterning,
including situs inversus, right pulmonary isomerism, TGA,
ventricular and atrial defects, and isomerisms.8,9 Since
Figure 1. Structural analysis of GDF1 mutations. A, Alignment of human GDF1 (hGDF1) and structurally related members of the TGF-
b family, including human BMP2 (hBMP2), human BMP7 (hBMP7), zebrafish DVR (zDVR), and murine Gdf1 (mGDF1). Amino acid residues
showing absolute identity are shown with white letters against a blue background; those positions with conservative substitutions are
shown against a yellow background. The positions of the five mutations considered in this study are indicated by arrowheads. The
amino acid numbering is based on that of the mature processed ligand. The b-sheet elements of the winglike finger projections F1 and
F2 are indicated by blackened arrows above the alignment, whereas the a-helical core is denoted by the cylinder above the alignment.
B, Ribbon diagram of human GDF1, showing the position of the mutations clustered in the knuckle region of the monomer. (Note that
the G9S variant lies within the poorly conserved N-terminal region of the protein where the crystal structure is unknown, precluding
accurate modeling of this mutation.)
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Table 1. Clinical and Molecular Findings in Patients with Cardiac Defects
Patient
GDF1
Mutation Laterality Defect(s) Other Finding(s)
1 R68H Atrioventricular canal with cleft mitral valve Left superior vena cava to coronary sinus and coarctation of the aorta
2 G162D TOF …
3 C227X TGA …
4 G262S (G9S) Ratelli type atrioventricular canal Left–pulmonary artery stenosis, hypoplastic left lung and pulmonary
veins, small secundum ASD, and trisomy 21
5 C267Y (C14Y) DORV Left–pulmonary artery stenosis
6 S309P (S56P) TOF Ventricular septal defect, aortic root dilatation, and bicuspid stenotic
pulmonary valve stenosis
7 P312T (P59T) TOF …
8 A318T (A69T) TGA …
Gdf1 requires the coreceptor Cfc1 to activate the mem-
brane receptors ActRIIB and ActRI,18 and since mutations
in human CFC1 (MIM *605194) are associated with later-
ality defects6 and isolated TGA,19 we considered GDF1 a
likely candidate gene for laterality/cardiac malformations.
Therefore, we set out to determine whether a similar spec-




Our study population consisted of 375 unrelated individuals with
a wide spectrum of congenital cardiovascular malformations, in-
cluding TGA, tetralogy of Fallot (TOF), DORV, atrial septal defect
(ASD), and interrupted aortic arch (IAA). Coded affected proband
DNA samples were obtained from three centers (The Children’s
Hospital of Philadelphia, Baylor College of Medicine, and Yale
University School of Medicine) in accordance with the guidelines
of the institutional review boards of each institution and with
the approval of the National Human Genome Research Institute
(NHGRI)/National Institutes of Health (NIH) Institutional Review
Board (for subjects with cardiac malformations or holoprosen-
cephaly [HPE]). Parents and siblings were not studied because of
the preliminary nature of the research, because the links to pa-
tient identifiers were retained by the host institutions, and to
maintain confidentiality. Additionally, we screened 198 unrelated
individuals with HPE and 225 unrelated, unaffected controls (ob-
tained as unrelated anonymous samples from the Coriell Institute
for Medical Research: 125 individuals studied by denaturing high-
pressure liquid chromatography [dHPLC] and 100 individuals by
bidirectional DNA sequencing of the entire coding region of the
gene). None of the disease-associated mutations detected in this
study were observed in the remaining cardiac cohort (742 chro-
mosomes), the HPE cohort (396 chromosomes), or the unaffected
controls (450 chromosomes).
PCR Amplifications, Mutation Screening, and DNA
Sequencing
The genomic organization of human GDF1 (GenBank accession
number NM_001492) was characterized using nucleotide ho-
mology searches in the public database, with use of the BLASTN
program. Oligo 4.1 was used to design primers: GDF1 exon 1,
forward 5′-CCCTCAGCCCACTGGTCCC-3′ and reverse 5′-GGCC-
GAAGTTGCTAGTAGCCTGG-3′; exon 2a, forward 5′-AGCCCCA-
GCGTTCACCTTCCTCC-3′ and reverse 5′-CACCAGCAGCAGCG-
AGGCCTC-3′; and exon 2b, forward 5′-CCGCTTGGGCTCGC-
AACGC-3′ and reverse 5′-CCAAGGAGACCAGCGGAGCAGACC-
3′. Amplification of genomic DNA was performed in a 30-ml re-
action volume, with the use of 60–100 ng DNA template, 50 mM
deoxynucleotide triphosphate, 0.25 mM of each primer, 3 ml of
10X PCR Amplification buffer (Invitrogen), 1.5 ml 10X Enhancer
buffer (Invitrogen), and 0.3 ml Taq polymerase. All reactions were
performed using a PTC-255 thermocycler (MJ Research). Typical
PCR cycling parameters were 95C for 4 min, followed by 30 cy-
cles at 95C, annealing at 62C, extension at 72C for 1 min, and
a final extension step of 72C for 5 min. One-half of the PCR
product was used for dHPLC analysis (WAVE [Trangenomic]), and
the remainder was retained for direct DNA sequencing.20 Ampli-
cons displaying heterozygous profiles were purified using a High
Pure PCR purification kit (Roche) and were bidirectionally se-
quenced using the BigDye version 3.1 terminator cycle sequenc-
ing kit in accordance with the manufacturer’s protocol (Applied
Biosystems) on an ABI 3100 automated sequencer. Sequence var-
iants likely to represent SNPs were also identified: L26L, A118V
(rs4800063), V130I, V304V, and L259L. Commonly occurring
duplications and deletions were 466-468dupGCG and 466-
468delGCG, and common intervening sequence variations in in-
tron 1 were IVS121GrA and IVS184GrA.
Site-Directed Mutagenesis and Construct Design
A chimeric construct of pCS2, BMP2 (Xenopus), and Gdf1 (P56S
murine) was used in the zebrafish Gdf1 overexpression assay. Site-
directed mutagenesis was performed, with minor modifications
of the Transformer kit (Promega) by Transponics, to introduce
the human missense changes onto the P56S murine Gdf1 protein
backbone.
Structural Molecular Modeling
Molecular modeling for the TGF-b domain of GDF1 was generated
using the MODELLER package,21 as implemented within Insight
II (Accelrys). Modeling was based on the solved nuclear magnetic
resonance structure of BMP7 (Protein Data Bank [PDB] 1LX5).22
The MODELLER program was run in fully automated mode with
a high optimization level to construct a minimized three-dimen-
sional model of the target sequence by satisfaction of spatial re-
straints extracted from the template PDB files. Three models were
generated for each of the target sequences. The stereochemistry
and geometry of the models were checked using PROCHECK.23
The model with the best parameters, as determined by PRO-
CHECK, was used for building mutant models.
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Figure 2. GDF1 activity assay by morphological phenotype.
Twenty picograms of mRNA synthesized from humanized wild-type
(WT) and mutant GDF1 constructs were injected at the one-cell
stage. Embryos were allowed to develop for 27 h and were assayed
for severity of developmental defects. Representative samples from
injected clutches are shown. WT humanized GDF1 exhibited the
severest developmental defects indicative of strongest activity.
Mutant GDF1 constructs exhibited varying degrees of decreased
activity compared with WT GDF1. Uninjected WT embryos are in-
cluded for comparison. Twenty picograms of LacZ mRNA was in-
jected as control and did not exhibit any phenotype (data not
shown). mGDF1 p murine GDF1.
Zebrafish Gdf1 Overexpression Assays
Plasmids were linearized with SacII, and the sense strand was
synthesized using the SP6 Message Machine kit (Ambion). Ze-
brafish embryos were dechorinated by pronase treatment and
were injected between the one- and four-cell stages. For pheno-
typic analysis, the zebrafish embryos at 27 h were mounted in
2% methylcellulose and were photographed using a Zeiss M2Bio
dissecting microscope. In situ hybridization was performed as
described elsewhere with goosecoid (gsc) or no-tail (ntl) probes.24
Results
Analysis of the Mutational Spectrum of GDF1
We screened a cohort of 375 unrelated individuals af-
fected with a wide spectrum of cardiovascular malfor-
mations, including TGA, DORV, TOF, and IAA. Eight dif-
ferent putative disease-causing mutations (table 1) were
detected in only one proband per mutation (1 of 750
chromosomes) and neither in 450 unaffected control
chromosomes nor in those of subjects with HPE (396 ad-
ditional chromosomes). Hence, these sequence variants
were highly correlated with the presence of cardiac mal-
formations. Interestingly, we did not detect any deleteri-
ous changes among the HPE cases, consistent with our
previous findings of the lack of CFC1 changes and the
rarity of changes in CRIPTO in this population group.6,20
Two mutations, C227X and C267Y (also referred to as
“C14Y”; see below), were considered likely loss-of-func-
tion mutations because of premature termination in the
prodomain (C227X) or elimination of one of the six cys-
teines crucial for the formation of the cystine knot (fig.
1). Two additional mutations in the prodomain (R68H and
G162D) could not be evaluated either structurally or func-
tionally (table 1) (see below).
Since the crystal structure of BMP7 has been solved,22
we were able to perform a structural analysis of four of
the missense changes in the TGF-b ligand domain (fig. 1A
and 1B). This domain contains six cysteine residues that
form three intramolecular disulfide bonds, resulting in
what has been termed a “cystine-knot” conformation.25,26
A cysteinertyrosine mutation at position 14 (C14Y) in-
terferes with the ability of this network of disulfide bonds
to form properly. The G9S variant lies within the poorly
conserved N-terminal region, whose crystal structure is
unknown. Interestingly, the S56P, P59T, and A69T mu-
tations are clustered in a portion of the molecule called
the “knuckle” region, which is implicated in dimerization
and overall stability of the core of the monomer. No mu-
tations have thus far been detected in the winglike finger
projections that make hydrophobic contacts with the re-
ceptor heterodimer.
We set out to assess the functional effects of GDF1 mu-
tations, using zebrafish as a model system. Previous studies
have established the zebrafish as a powerful assay system
in which to study the activity of TGF-b signaling com-
ponents.6,18–20,27–31 A chimeric protein consisting of the ma-
ture region of murine Gdf1 and the Xenopus BMP2 pro-
domain has been shown elsewhere to induce mesodermal
marker expression and patterning defects in zebrafish.18
Since P56 is the normal residue in the murine protein (and
corresponds to the amino acid change in patient 6), we
changed P56 to serine to humanize the murine GDF1.
Mutant residues G9S, C14Y, S56P, P59T, and A69T were
incorporated into this GDF1 derivative. We did not test
the sixth mutation (C227X), since premature termination
is not compatible with the production of an active ligand.
Overexpression of Gdf1 led to a strong induction of the
downstream targets ntl and gsc (figs. 2 and 3) and to de-
velopmental defects detected at later stages of develop-
ment (fig. 4). Previous studies have established that the
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Figure 3. GDF1 activity assay by gsc induction. As in figure 2,
injected embryos were fixed and stained for gsc. gsc is a higher-
threshold target of GDF1; thus, higher amounts of mRNA (200 pg)
were injected per embryo. mGDF1 p murine GDF1.
Figure 4. GDF1 activity assay by induction of ntl expression.
Twenty picograms of mRNA synthesized from humanized wild-type
(WT) and mutant GDF1 constructs were injected at the one-cell
stage. Embryos were allowed to develop for 5 h and were fixed
and stained for ntl, a downstream target of GDF1. Representative
animal samples from injected clutches are shown. Mutant GDF1
constructs exhibited varying degrees of decreased activity com-
pared with WT GDF1, as assessed by the extent of ectopic ntl
induction. Stained samples from uninjected WT embryos are in-
cluded for comparison. mGDF1 p murine GDF1.
ectopic activation of Nodal/GDF1/activin signaling leads
to the induction of downstream genes such as gsc and ntl
and to defects in axis formation. Moreover, the extent of
downstream gene expression reflects the activity of the
pathways.6,18–20,27–34 In contrast, the mutants G9S, C14Y,
S56P, P59T, and A69T were significantly attenuated in
these activities (figs. 2–5). These results indicate that the
human GDF1 mutations constitute hypomorphic or loss-
of-function alleles.
Discussion
The phenotypes observed with the GDF1 loss-of-function
mutations are consistent with a model of disturbed L-R
patterning, with incomplete establishment of left-sided
identity. TGA (as for patients 3 and 8) and DORV (as for
patient 5) can be seen in mice lacking Gdf1 or Cfc1.8,9,35,
36 Similar defects are seen in humans with loss-of-function
mutations in CFC119 (authors’ unpublished data), the es-
sential coreceptor for NODAL/GDF1. Interestingly, pa-
tients 4 and 5 manifest stenosis of the left pulmonary
artery, suggestive of deficiency of left-sided anterior mes-
oderm. Patient 4 displays an atrioventricular-canal de-
fect. Although this malformation is typically attributed to
a primary disturbance in endocardial cushion develop-
ment, as commonly seen in Down syndrome, the left–
pulmonary artery stenosis and left-lung hypoplasia are not
associated with Down syndrome atrioventricular septal
defects. In addition, atrioventricular canal defects are
commonly associated with the complex cardiovascular
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Figure 5. Classification and quantification of morphological phenotypes. Embryos aged 27 h injected with GDF1 constructs were sorted
into classes I–IV (from wild type [WT] to those with the severest developmental defects) and were quantified. All mutant constructs
exhibited varying degrees of decreased activity compared with WT humanized GDF1. mGDF1 p murine GDF1. Red font indicates the
predominant class.
malformations seen in heterotaxy. These observations
support the argument that the GDF1 mutation contributes
in this case and acts in concert with the effects of the
trisomy 21 as well. Finally, patients 6 and 7 have TOF, a
complex malformation attributed to the primary malfor-
mations (the pulmonic stenosis with overriding aorta) and
to the secondary associated features (the obligate ventric-
ular septal defect and development of right ventricular
hypertrophy). Our findings suggest that septation of the
conotruncus and development of the aortic and pulmonic
valves are affected by L-R patterning influences in hu-
mans. A specific role for Pitx2, whose expression may be
altered by Gdf1 deficiency, has recently been established
in the development of the second cardiac lineage myo-
cardium in mice.37 The phenotypes of patients 1 and 2 are
also compatible with L-R defects (e.g., TOF, AVC, and per-
sistent left superior cava). However, additional functional
studies will be needed to prove whether these mutations
are also pathogenic.
An important observation that distinguishes these stud-
ies in humans from those described in mice is the presence
of cardiac malformations in the context of heterozygous
mutations in GDF1. Inbred strains of mice heterozygous
for mutations in Gdf1 are described as phenotypically
normal. In contrast, mice null for Gdf1 display extremes
of heterotaxy not observed in our human subjects (e.g.,
right pulmonary isomerism). We propose that mutations
in GDF1 constitute only one genetic susceptibility trait in
an otherwise multifactorial disorder (i.e., CHD) with het-
erogeneous causes, including environmental and poten-
tially additional genetic modifiers. None of our subjects
had known signs of heterotaxy of abdominal organs, sug-
gesting that L-R determination defects attributed to het-
erozygous mutations in GDF1 might affect some organs
and not others.
Recent studies in mice suggest that it is best to view the
total TGF-b signaling strength—and not just the contri-
bution of a single factor—for a particular patterning event.
With respect to axis formation in the mouse, a synergistic
interaction was observed between Gdf1/ and Nodal/
genotypes, which was not seen in either genotype alone.38
Whereas Gdf1/ mice exhibit cardiac and laterality de-
fects but normal axis development, the reduction of a sin-
gle copy of the Nodal gene reveals novel midline abnor-
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malities, including HPE, in some cases. These findings
reveal that there are different thresholds for TGF-b sig-
naling required for different patterning functions. The ob-
servation that only the genotypes with the most-severe
reductions in TGF-b signaling affect the midline with less
pronounced reductions, leading to laterality and cardiac
malformations, is entirely consistent with the paucity of
detectable mutations we observed in our HPE cohort. By
extension of this general concept, it is reasonable to pos-
tulate that reduction of effective GDF1 signaling in hu-
mans could result in cardiac malformations without the
simultaneous manifestations of right-sided isomerism
seen in Gdf1-null mice. Similar evidence for a spectrum
of phenotypic effects attributed to gradations of attenu-
ated Nodal signaling have been well described in the
mouse and zebrafish.39–41
Dissecting the full range of genetic and environmental
contributors to human CHD is a challenging problem. We
hypothesize that complex disorders arise from the inter-
play between rare mutations and more-common genetic
or environmental modifiers and that detected mutations
must always be considered in the broader context of these
interacting factors.42 Our studies suggest that mutations
in GDF1 are likely to contribute to a distinct subclass of
CHD, especially affecting the conotruncus, and a more
targeted mutation search based on a more narrow spec-
trum of phenotypes may be indicated. It will be important
to assess the penetrance of GDF1 mutations in family stud-
ies and to search for evidence of additional genetic and
environmental modifiers. In this regard, mutations in the
entire pathway of L-R determination may be considered
candidates for CHD on the basis of a similar mechanism
identified for human GDF1.
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